There are 717 resources available
242MO - Sarcopenia as A Predictor of Overall Survival in Patients with Ovarian Cancer Undergoing Chemotherapy : A Systematic Review and Meta-Analysis
Presenter: Vika Damay
Session: Mini oral session on Gynaecological tumours
Resources:
Abstract
Slides
Webcast
80MO - Gut microbiome analysis for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer patients
Presenter: Yuxi Yi
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
81MO - Clinical experience of a personalized and tumour-informed circulating tumour DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
Presenter: Stacey Cohen
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
82MO - Automatical risk stratifying for colorectal cancer by deep learning based pathological score
Presenter: Shenlun Chen
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
83MO - AMG 510, a novel small molecule inhibitor of KRAS(G12C), for patients (pts) with advanced gastrointestinal (GI) cancers: Results from the CodeBreaK100 phase I trial
Presenter: Timothy Price
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
84MO - A phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-expressing metastatic colorectal cancer (mCRC): DESTINY-CRC01
Presenter: Takayuki Yoshino
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
85MO - Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E mutant metastatic colorectal cancer (BEACON CRC Study)
Presenter: Chang-Fang Chiu
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
332MO - Comparison of NEPA-based versus olanzapine/aprepitant-based antiemetic regimen for Chinese breast cancer patients undergoing highly emetogenic chemotherapy
Presenter: Winnie Yeo
Session: Mini oral session on Supportive and palliative care
Resources:
Abstract
Slides
Webcast
333MO - Cost-utility analysis of olanzapine in Japanese patients treated with cisplatin-containing highly emetogenic chemotherapy
Presenter: Yu Kondo
Session: Mini oral session on Supportive and palliative care
Resources:
Abstract
Slides
Webcast
290MO - Patient controlled analgesia (PCA) versus non-pca intravenous hydromorphone for severe cancer pain: Update from a multi-center, phase III randomized trial, HMORCT09-1
Presenter: Rongbo Lin
Session: Mini oral session on Supportive and palliative care
Resources:
Abstract
Slides
Webcast